China Biologic Products Holdings, Inc. (Form: SC 13D/A, Received: 05/07/2020 08:30:10)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 12)*

China Biologic Products Holdings, Inc.
(Name of Issuer)

Ordinary Shares, Par Value $0.0001
(Title of Class of Securities)

G21515104
(CUSIP Number)

Andrew Chan
Chief Financial Officer
Centurium Capital Management Ltd.
Suite 1008, Two Pacific Place, 88 Queensway, Hong Kong
+852 3643 0755

(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)

May 5, 2020

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 1(f) or 1(g), check the following box. ☐

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. G21515104
1.		Names of Reporting Persons. Beachhead Holdings Limited
2.		Check the Appropriate Box if a Member of a Group (See Instructions). (a) ý (b) ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization Cayman Islands
Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power 0
	8.	Shared Voting Power 7,908,726 Ordinary Shares (See Item 5)
	9.	Sole Dispositive Power 0
	10.	Shared Dispositive Power 7,908,726 Ordinary Shares (See Item 5)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person 7,908,726 Ordinary Shares (See Item 5)
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ☐
13.		Percent of Class Represented by Amount in Row (11) 20.6%⁽¹⁾
14.		Type of Reporting Person (See Instructions) CO

(1)

Percentage calculated based on 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported by the Issuer’s Form 20-F filed on March 12, 2020.

CUSIP No. G21515104
1.		Names of Reporting Persons. Double Double Holdings Limited
2.		Check the Appropriate Box if a Member of a Group (See Instructions). (a) ý (b) ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization Cayman Islands
Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power 0
	8.	Shared Voting Power 775,000 Ordinary Shares (See Item 5)⁽¹⁾
	9.	Sole Dispositive Power 0
	10.	Shared Dispositive Power 775,000 Ordinary Shares (See Item 5)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person 775,000 Ordinary Shares (See Item 5)
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ☐
13.		Percent of Class Represented by Amount in Row (11) 2.0%⁽²⁾
14.		Type of Reporting Person (See Instructions) CO

(1)

Includes 615,000 Ordinary Shares that Double Double has agreed to purchase from PWM pursuant to the PWM SPA and the Double Double Assignment Agreement, which is subject to customary closing conditions.

(2)

Percentage calculated based on 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported by the Issuer’s Form 20-F filed on March 12, 2020.

CUSIP No. G21515104
1.		Names of Reporting Persons. Point Forward Holdings Limited
2.		Check the Appropriate Box if a Member of a Group (See Instructions). (a) ý (b) ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions) OO
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization Cayman Islands
Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power 0
	8.	Shared Voting Power 1,986,265 Ordinary Shares (See Item 5) ⁽¹⁾
	9.	Sole Dispositive Power 0
	10.	Shared Dispositive Power 1,986,265 Ordinary Shares (See Item 5)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person 1,986,265 Ordinary Shares (See Item 5)
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ☐
13.		Percent of Class Represented by Amount in Row (11) 5.2%⁽²⁾
14.		Type of Reporting Person (See Instructions) CO

(1)

Includes 385,000 Ordinary Shares that Point Forward has agreed to purchase from PWM pursuant to the PWM SPA and the Point Forward Assignment Agreement, which is subject to customary closing conditions.

(2)

Percentage calculated based on 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported by the Issuer’s Form 20-F filed on March 12, 2020.

CUSIP No. G21515104
1.		Names of Reporting Persons. Centurium Capital Partners 2018, L.P.
2.		Check the Appropriate Box if a Member of a Group (See Instructions). (a) ý (b) ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions) N/A
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization Cayman Islands
Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power 0
	8.	Shared Voting Power 8,683,726 Ordinary Shares (See Item 5)⁽¹⁾
	9.	Sole Dispositive Power 0
	10.	Shared Dispositive Power 8,683,726 Ordinary Shares (See Item 5)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person 8,683,726 Ordinary Shares (See Item 5)
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ☐
13.		Percent of Class Represented by Amount in Row (11) 22.6%⁽²⁾
14.		Type of Reporting Person (See Instructions) PN

(1)

(2)

Percentage calculated based on 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported by the Issuer’s Form 20-F filed on March 12, 2020.

CUSIP No. G21515104
1.		Names of Reporting Persons. Centurium Capital Partners 2018 GP Ltd.
2.		Check the Appropriate Box if a Member of a Group (See Instructions). (a) ý (b) ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions) N/A
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization Cayman Islands
Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power 0
	8.	Shared Voting Power 8,683,726 Ordinary Shares (See Item 5)⁽¹⁾
	9.	Sole Dispositive Power 0
	10.	Shared Dispositive Power 8,683,726 Ordinary Shares (See Item 5)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person 8,683,726 Ordinary Shares (See Item 5)
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ☐
13.		Percent of Class Represented by Amount in Row (11) 22.6%⁽²⁾
14.		Type of Reporting Person (See Instructions) CO

(1)

(2)

Percentage calculated based on 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported by the Issuer’s Form 20-F filed on March 12, 2020.

CUSIP No. G21515104
1.		Names of Reporting Persons. Centurium Capital 2018 Co-invest, L.P.
2.		Check the Appropriate Box if a Member of a Group (See Instructions). (a) ý (b) ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions) N/A
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization Cayman Islands
Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power 0
	8.	Shared Voting Power 1,316,265 Ordinary Shares (See Item 5) ⁽¹⁾
	9.	Sole Dispositive Power 0
	10.	Shared Dispositive Power 1,316,265 Ordinary Shares (See Item 5)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person 1,316,265 Ordinary Shares (See Item 5)
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ☐
13.		Percent of Class Represented by Amount in Row (11) 3.4% ⁽²⁾
14.		Type of Reporting Person (See Instructions) CO

(1)

(2)

Percentage calculated based on 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported by the Issuer’s Form 20-F filed on March 12, 2020.

CUSIP No. G21515104
1.		Names of Reporting Persons. CCM CB I, L.P.
2.		Check the Appropriate Box if a Member of a Group (See Instructions). (a) ý (b) ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions) N/A
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization Cayman Islands
Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power 0
	8.	Shared Voting Power 670,000 Ordinary Shares (See Item 5) ⁽¹⁾
	9.	Sole Dispositive Power 0
	10.	Shared Dispositive Power 670,000 Ordinary Shares (See Item 5)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person 670,000 Ordinary Shares (See Item 5)
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ☐
13.		Percent of Class Represented by Amount in Row (11) 1.7% ⁽²⁾
14.		Type of Reporting Person (See Instructions) CO

(1)

(2)

Percentage calculated based on 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported by the Issuer’s Form 20-F filed on March 12, 2020.

CUSIP No. G21515104
1.		Names of Reporting Persons. Centurium Capital 2018 SLP-B Ltd.
2.		Check the Appropriate Box if a Member of a Group (See Instructions). (a) x (b) ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions) N/A
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ¨
6.		Citizenship or Place of Organization Cayman Islands
Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power 0
	8.	Shared Voting Power 1,316,265 Ordinary Shares (See Item 5) ⁽¹⁾
	9.	Sole Dispositive Power 0
	10.	Shared Dispositive Power 1,316,265 Ordinary Shares (See Item 5)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person 1,316,265 Ordinary Shares (See Item 5)
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ¨
13.		Percent of Class Represented by Amount in Row (11) 3.4%⁽¹⁾
14.		Type of Reporting Person (See Instructions) CO

(1)

(2)

Percentage calculated based on 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported by the Issuer’s Form 20-F filed on March 12, 2020.

CUSIP No. G21515104
1.		Names of Reporting Persons. CCM CB I Limited
2.		Check the Appropriate Box if a Member of a Group (See Instructions). (a) ý (b) ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions) N/A
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization Cayman Islands
Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power 0
	8.	Shared Voting Power 670,000 Ordinary Shares (See Item 5) ⁽¹⁾
	9.	Sole Dispositive Power 0
	10.	Shared Dispositive Power 670,000 Ordinary Shares (See Item 5)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person 670,000 Ordinary Shares (See Item 5)
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ☐
13.		Percent of Class Represented by Amount in Row (11) 1.7% ⁽²⁾
14.		Type of Reporting Person (See Instructions) CO

(1)

(2)

Percentage calculated based on 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported by the Issuer’s Form 20-F filed on March 12, 2020.

CUSIP No. G21515104
1.		Names of Reporting Persons. Centurium Holdings Ltd.
2.		Check the Appropriate Box if a Member of a Group (See Instructions). (a) ý (b) ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions) N/A
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
6.		Citizenship or Place of Organization Cayman Islands
Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power 0
	8.	Shared Voting Power 10,669,991 Ordinary Shares (See Item 5)⁽¹⁾
	9.	Sole Dispositive Power 0
	10.	Shared Dispositive Power 10,669,991 Ordinary Shares (See Item 5)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person 10,669,991 Ordinary Shares (See Item 5)
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ☐
13.		Percent of Class Represented by Amount in Row (11) 27.7%⁽²⁾
14.		Type of Reporting Person (See Instructions) CO

(1)

Includes (i) Includes 615,000 Ordinary Shares that Double Double has agreed to purchase from PWM pursuant to the PWM SPA and the Double Double Assignment Agreement, which is subject to customary closing conditions, and (ii)385,000 Ordinary Shares that Point Forward has agreed to purchase from PWM pursuant to the PWM SPA and the Point Forward Assignment Agreement, which is subject to customary closing conditions..

(2)

Percentage calculated based on 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported by the Issuer’s Form 20-F filed on March 12, 2020.

CUSIP No. G21515104
1.		Names of Reporting Persons. Centurium Holdings (BVI) Ltd.
2.		Check the Appropriate Box if a Member of a Group (See Instructions). (a) x (b) ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions) N/A
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ¨
6.		Citizenship or Place of Organization British Virgin Islands
Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power 0
	8.	Shared Voting Power 10,669,991 Ordinary Shares (See Item 5)⁽¹⁾
	9.	Sole Dispositive Power 0
	10.	Shared Dispositive Power 10,669,991 Ordinary Shares (See Item 5)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person 10,669,991 Ordinary Shares (See Item 5)
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ¨
13.		Percent of Class Represented by Amount in Row (11) 27.7%⁽²⁾
14.		Type of Reporting Person (See Instructions) CO

(1)

(2)

Percentage calculated based on 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported by the Issuer’s Form 20-F filed on March 12, 2020.

CUSIP No. G21515104
1.		Names of Reporting Persons. Hui Li
2.		Check the Appropriate Box if a Member of a Group (See Instructions). (a) x (b) ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions) N/A
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ¨
6.		Citizenship or Place of Organization Hong Kong
Number of Shares Beneficially Owned by Each Reporting Person With	7.	Sole Voting Power 28,269 Ordinary Shares (See Item 5)
	8.	Shared Voting Power 10,669,991 Ordinary Shares (See Item 5)⁽¹⁾
	9.	Sole Dispositive Power 28,269 Ordinary Shares (See Item 5)
	10.	Shared Dispositive Power 10,669,991 Ordinary Shares (See Item 5)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person 10,698,260 Ordinary Shares (See Item 5)⁽²⁾
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ¨
13.		Percent of Class Represented by Amount in Row (11) 27.8%⁽³⁾
14.		Type of Reporting Person (See Instructions) IN

(1)

Includes (i) Includes 615,000 Ordinary Shares that Double Double has agreed to purchase from PWM pursuant to the PWM SPA and the Double Double Assignment Agreement, which is subject to customary closing conditions, and (ii) 385,000 Ordinary Shares that Point Forward has agreed to purchase from PWM pursuant to the PWM SPA and the Point Forward Assignment Agreement, which is subject to customary closing conditions..

(2)

Represents (i) 28,269 Ordinary Shares directly held by Mr. David Hui Li and (ii) 10,669,991 Ordinary Shares deemed to be beneficially owned by Mr. Li, through Beachhead, Double Double and Point Forward.

(3)

Percentage calculated based on 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported by the Issuer’s Form 20-F filed on March 12, 2020.

Pursuant to Rule 13d-2 promulgated under the Act, this amendment to Schedule 13D (this “Amendment No. 12”) amends and supplements the Schedule 13D filed on September 14, 2018, as amended by Amendment No. 1 filed on November 19, 2018, by Amendment No. 2 filed on December 18, 2018, by Amendment No. 3 filed on January 8, 2019, by Amendment No. 4 filed on February 4, 2019, by Amendment No. 5 filed on March 12, 2019, by Amendment No. 6 filed on September 19, 2019, by Amendment No. 7 filed on November 18, 2019, by Amendment No. 8 filed on January 24, 2020, by Amendment No. 9 filed on March 20, 2020, by Amendment No. 10 filed on April 10, 2020, and by Amendment No. 11 filed on May 1, 2020 (the “Schedule 13D”), with respect to the ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), of China Biologic Products Holdings, Inc., a company organized under the laws of the Cayman Islands (the “Issuer”).

Except as specifically provided herein, this Amendment No. 12 does not modify any of the information previously reported in the Schedule 13D. All capitalized terms used and not defined herein have the meanings given to such terms in the Schedule 13D.

Item 4. Purpose of Transaction.

Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following at the end thereof:

On May 4, 2020, in order to enable discussions and negotiations among members of the Buyer Consortium and the management members of the Issuer or its subsidiaries (the “Management Members”) regarding the potential treatment of the equity securities of the Issuer beneficially owned by such Management Members in connection with the Proposed Transaction, the Board has granted to members of the Buyer Consortium and certain of their affiliates a waiver from complying with certain restrictions under (i) the investor rights agreements entered into by and between each of Beachhead, PWM, CITIC Capital MB Investment Limited (an affiliate of CITIC Capital) and HH China Bio Holdings LLC (an affiliate of Hillhouse), respectively, and the Issuer, and (ii) the confidentiality agreements, dated as of October 20, 2019, entered into by each of Beachhead, PWM, CITIC Capital, Hillhouse and Temasek, respectively, and the Issuer. The Board has also determined that none of the parties to the waiver letter, the Management Members and the respective affiliates of the foregoing will not be deemed to be an “Acquiring Person” under the Issuer’s currently effective preferred shares rights agreement, nor shall any provision under such preferred shares rights agreement be otherwise triggered for discussing or negotiating with the Management Members regarding the potential treatment of the equity securities of the Issuer beneficially owned by such Management Members in connection with the Proposed Transaction or taking any other action that is permitted by the waiver. The waiver will expire on May 18, 2020.

On May 5, 2020, PWM and Beachhead entered into an amendment No. 2 to the PWM SPA (the “PWM SPA Amendment No. 2”), pursuant to which PWM and Beachhead have agreed to, among others, waive the closing condition under the PWM SPA with respect to the execution of a definitive agreement for the Proposed Transaction.

On May 5, 2020, Beachhead and PWM entered into (i) an assignment agreement with Double Double (the “Double Double Assignment Agreement”), pursuant to which Beachhead assigned its rights and obligations with respect to the purchase of 615,000 Ordinary Shares under the PWM SPA (as amended by the PWM SPA Amendment No. 1 and the PWM SPA Amendment No. 2) to Double Double, and (ii) an assignment agreement with Point Forward (the “Point Forward Assignment Agreement”), pursuant to which Beachhead assigned its rights and obligations with respect to the purchase of 385,000 Ordinary Shares under the PWM SPA (as amended by the PWM SPA Amendment No. 1 and the PWM SPA Amendment No. 2) to Point Forward.

On May 6, 2020, Double Double completed the sale of 210,876 Ordinary Shares to Hillhouse, pursuant to the terms and conditions of the applicable Centurium SPA.

References to the PWM SPA Amendment No. 2 in this Amendment No. 12 are qualified in their entirety by reference to the PWM SPA Amendment No. 2, a copy of which is attached hereto as Exhibit 1 incorporated herein by reference in its entirety.

Item 5. Interest in Securities of the Issuer.

Item 5 of the Schedule 13D is hereby amended and restated in its entirety to read as follows:

(a)–(b) The following information with respect to the ownership of Ordinary Shares by the Reporting Persons filing this statement on Schedule 13D is provided as of the date of this filing:

Reporting Persons	Ordinary Shares Held Directly		Shared Voting Power		Shared Dispositive Power		Beneficial Ownership		Percentage ⁽³⁾
Beachhead		7,908,726		7,908,726		7,908,726		7,908,726		20.6	%
Double Double⁽¹⁾		775,000		775,000		775,000		775,000		2.0	%
Point Forward⁽¹⁾		1,986,265		1,986,265		1,986,265		1,986,265		5.2	%
CCP 2018 ^{(1) (2)}		0		8,683,726		8,683,726		8,683,726		22.6	%
Centurium GP ^{(1) (2)}		0		8,683,726		8,683,726		8,683,726		22.6	%
CCCI 2018^{(1) (2)}		0		1,316,265		1,316, 265		1,316,265		3.4	%
Centurium SLP-B^{(1) (2)}		0		1,316,265		1,316,265		1,316,265		3.4	%
CCM CB I^{(1) (2)}		0		670,000		670,000		670,000		1.7	%
CCM CB I GP^{(1) (2)}		0		670,000		670,000		670,000		1.7	%
Centurium GP Holdco ^{(1) (2)}		0		10,669,991		10,669,991		10,669,991		27.7	%
Centurium TopCo ^{(1) (2)}		0		10,669,991		10,669,991		10,669,991		27.7	%
Mr. Hui Li ^{(1) (2) (4)}		28,269		10,669,991		10,669,991		10,698,260		27.8	%

(1)

The number of Ordinary Shares beneficially owned by such Reporting Person includes (i) 615,000 Ordinary Shares that Double Double has agreed to purchase from PWM pursuant to the PWM SPA and the Double Double Assignment Agreement, which is subject to customary closing conditions, and (ii)385,000 Ordinary Shares that Point Forward has agreed to purchase from PWM pursuant to the PWM SPA and the Point Forward Assignment Agreement, which is subject to customary closing.

(2)

Each of Beachhead and Double Double is 100% owned by CCP 2018. Point Forward is 66.3% owned by CCCI 2018 and 33.7% owned by CCM CB I. Centurium GP is the general partner to CCP 2018, Centurium SLP-B is the general partner to CCCI 2018 and CCM CB I GP is the general partner of CCM CB I. Centurium GP Holdco and Centurium TopCo are the direct and indirect sole shareholders of Centurium GP, Centurium SLP-B and CCM CB I GP, respectively, and Mr. Li is the sole shareholder of Centurium TopCo. As such, each of CCP 2018, Centurium GP, Centurium GP Holdco, Centurium TopCo and Mr. Li may exercise voting and dispositive power over the Ordinary Shares held by Beachhead and Double Double, and each of CCCI 2018, CCM CB I, Centurium SLP-B, CCM CB I GP, Centurium GP Holdco, Centurium TopCo and Mr. Li may exercise voting and dispositive power over the Ordinary Shares held by Point Forward.

(3)

Percentage calculated based on 38,480,580 Ordinary Shares issued and outstanding as of March 9, 2020 as reported by the Issuer’s Form 20-F filed on March 12, 2020.

(4)

Represents (i) 28,269 Ordinary Shares directly held by Mr. David Hui Li, and (ii) 10,669,991 Ordinary Shares deemed to be beneficially owned by Mr. Li, through Beachhead, Double Double and Point Forward.

Because of the arrangements in the Consortium Agreement, the parties to that agreement are deemed to have formed a “group” for purposes of Section 13(d)(3) of the Act, and such “group” is deemed to beneficially own an aggregate of 26,374,631 Ordinary Shares, which represents approximately 68.5% of the total number of Ordinary Shares issued and outstanding as of March 9, 2020 as reported in the Issuer’s Form 20-F filed on March 12, 2020. Neither the filing of this Amendment No. 11 nor any of its contents, however, shall be deemed to constitute an admission by the Reporting Persons that any of them is the beneficial owner of any of the 15,704,640 Ordinary Shares beneficially owned in the aggregate by PWM, Parfield, CITIC Capital, Hillhouse, and Temasek and their respective affiliates for purposes of Section 13(d) of the Act or for any other purpose, and such beneficial ownership is expressly disclaimed.

(c) Except as set forth herein, to the knowledge of the Reporting Persons with respect to the persons named in response to Item 5(a)-(b), none of the persons named in response to Item 5(a)-(b) has effected any transactions in the Ordinary Shares during the past 60 days.

(d) Except as disclosed in Item 2, no person is known to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any securities covered by this Amendment No. 11.

(e) Not applicable.

Item 6. Contracts, Arrangement, Understandings or Relationships with Respect to Securities of the Issuer.

Item 6 of the Schedule 13D is hereby amended and supplemented by adding the following at the end thereof:

The descriptions of the principal terms of the PWM SPA Amendment No. 2, the Double Double Assignment Agreement and the Point Forward Assignment Agreement under Item 4 are incorporated herein by reference in their entirety.

Item 7. Materials to be Filed as Exhibits.

Exhibit 1 PWM SPA Amendment No. 2, dated as of May 5, 2020, by and between PWM and Beachhead.

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

	Date: May 7, 2020

	BEACHHEAD HOLDINGS LIMITED


	By:	/s/ Hui Li
		Name: HUI LI
		Title: Director

	DOUBLE DOUBLE HOLDINGS LIMITED


	By:	/s/ Hui Li
		Name: HUI LI
		Title: Director

	POINT FORWARD HOLDINGS LIMITED


	By:	/s/ Hui Li
		Name: HUI LI
		Title: Director

	CENTURIUM CAPITAL PARTNERS 2018, L.P.


	By:	CENTURIUM CAPITAL PARTNERS 2018 GP LTD., GENERAL PARTNER


	By:	/s/ Hui Li
		Name: HUI LI
		Title: Director

	CENTURIUM CAPITAL PARTNERS 2018, GP LTD.


	By:	/s/ Hui Li
		Name: HUI LI
		Title: Director

	CENTURIUM CAPITAL 2018 CO-INVEST, L.P.


	By:	CENTURIUM CAPITAL 2018 SLP-B LTD., GENERAL PARTNER


	By:	/s/ Hui Li
		Name: HUI LI
		Title: Director

	CENTURIUM CAPITAL 2018 SLP-B LTD.


	By:	/s/ Hui Li
		Name: HUI LI
		Title: Director

	CCM CB I, L.P.


	By:	CCM CB I Limited, GENERAL PARTNER


	By:	/s/ Hui Li
		Name: HUI LI
		Title: Director

	CCM CB I Limited


	By:	/s/ Hui Li
		Name: HUI LI
		Title: Director

	CENTURIUM HOLDINGS LTD.


	By:	/s/ Hui Li
		Name: HUI LI
		Title: Director

	CENTURIUM HOLDINGS (BVI) LTD.


	By:	/s/ Hui Li
		Name: HUI LI
		Title: Director

	HUI LI


	By:	/s/ Hui Li

Exhibit 1

AMENDMENT NO. 2 TO SHARE PURCHASE AGREEMENT

THIS AMENDMENT NO. 2 TO SHARE PURCHASE AGREEMENT (this “Amendment”), dated as of May 5, 2020, is entered into by and between PW Medtech Group Limited, a Cayman Islands company (the “Seller”) and Beachhead Holdings Limited, a Cayman Islands company (the “Purchaser”).

WHEREAS, the parties hereto entered into a share purchase agreement dated as of September 18, 2019 (as amended by the Amendment No. 1 to Share Purchase Agreement dated as of March 17, 2020, the “SPA”), pursuant to and subject to the terms and conditions of which, the Seller has agreed to sell to the Purchaser, and the Purchaser has agreed to purchase from the Seller the Sale Shares;

WHEREAS, Section 6.4 of the SPA provides that the SPA may be amended by written instrument making specific reference to the SPA signed by the party of the SPA against whom enforcement of such amendment is sought; and

WHEREAS, the parties hereto desire to amend the SPA pursuant to the terms as set forth herein.

NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

1. Definitions. All capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the SPA.

2. Amendments to SPA. Section 1.2(b) of the SPA is hereby amended and restated in its entirety to read as follows:

“(b) At the Closing:

(i)

the Seller shall deliver, or cause its broker to deliver, to the Purchaser:

(A)

the Sale Shares on a settlement by delivery against payment basis; and

(B)

a copy of the director resolutions of the Seller duly authorizing and approving this Agreement and the transactions contemplated hereby; and

(ii)

the Purchaser shall deliver, or cause its broker to deliver, to the Seller:

(A)

immediately available funds by wire transfer into an account designated by the Seller in the amount of the Purchase Price on a settlement by payment against delivery basis; and

(B)

a copy of the director resolutions of the Purchaser duly authorizing and approving this Agreement and the transactions contemplated hereunder.”

3. No Further Amendment. The parties hereto agree that all other provisions of the SPA shall, subject to Section 2 of this Amendment, continue unmodified, in full force and effect and constitute legal and binding obligations of the parties hereto in accordance with their terms. This Amendment forms an integral and inseparable part of the SPA.

4. Additional Seller’s Representations and Warranties. The Seller hereby makes a representation and warranty to the Purchaser as of the date of this Amendment and the Closing Date that the shareholders of the Seller have duly approved the transactions contemplated by the SPA at an Extraordinary General Meeting of the Seller in accordance with requirements of the Hong Kong Listing Rules and the Organizational Documents of the Seller.

5. Waiver of Conditions.

(a) The Seller hereby irrevocably and unconditionally waives Section 4.1(c) of the SPA as a condition to its obligations to consummate the Closing, and Section 4.1(c) of the SPA shall, from the date hereof, no longer be a condition to the Seller’s obligations to consummate the Closing.

(b) The Purchaser hereby irrevocably and unconditionally waives Section 4.2(c) of the SPA as a condition to its obligations to consummate the Closing, and Section 4.2(c) of the SPA shall, from the date hereof, no longer be a condition to the Purchaser’s obligations to consummate the Closing.

6. References. All references to the SPA (including “hereof,” “herein,” “hereunder,” “hereby” and “this Agreement”) in the SPA shall refer to the SPA as amended by this Amendment. Notwithstanding the foregoing, references to the date of the SPA (as amended hereby) and references in the SPA to “the date hereof,” “the date of this Agreement” and terms of similar import shall in all instances continue to refer to September 18, 2019.

7. Other Miscellaneous Terms. The provisions of Sections 6.4 (Complete Agreement; Amendments; Waivers), 6.5 (Expenses), 6.6 (Severability), 6.7 (Binding Effect; Assignment), 6.8 (Governing Law), 6.9 (Dispute Resolution), 6.10 (Notices), 6.11 (Survival), 6.12 (Section and Other Headings), and 6.13 (Counterparts) of the SPA shall apply mutatis mutandis to this Amendment, and to the SPA as modified by this Amendment, taken together as a single agreement, reflecting the terms therein as modified by this Amendment.

[SIGNATURE PAGES FOLLOW]

IN WITNESS WHEREOF, each of the parties hereto has executed this Amendment as of the day and year first above written.

	PW Medtech Group Limited (普华和顺集团公司)



	By:	/s/ Yue’e Zhang
	Name: Title:	Yue’e Zhang Executive Director

IN WITNESS WHEREOF, each of the parties hereto has executed this Amendment as of the day and year first above written.

	Beachhead Holdings Limited



	By:	/s/ Hui Li
	Name: Title:	Hui Li Director